Product Wiki · Recalls · EU Safety Gate (RAPEX)

Odkamieniacz w płynie — recall SR/02497/26

EU Safety Gate (RAPEX) · Latvia · 2026-09-18 · Serious risk

Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked on this page. No AI-generated text appears on this page. How we use AI →
Agency
EU Safety Gate (RAPEX)
Recall identifier
SR/02497/26
Date of alert
2026-09-18
Country / jurisdiction
Latvia
Risk level
Serious risk
Risk type
Chemical
Brand
Tytan
Product category
Chemical products
Product type
Limescale remover
Barcode (EAN/GTIN)
5900657303309
🔴 Serious hazard — Reported risk: The product is extremely acid (pH value of 0.67) and can cause severe skin corrosion (Category 1) and eye damage. The product is incorrectly labelled and the appropriate pictograms are missing. Users are therefore not properly informed about the dangers incurred when the product comes into contact with the skin and eyes. The product does not comply with the Regulation on the classification, labelling and packaging of substances and mixtures (CLP).
What to do

Check whether your product matches this notice (name, batch, dates). If it does, stop using it and follow the instructions in the official notice — refund, return, repair or disposal are set by the issuing authority and the business, and they differ per recall. Official notice from EU Safety Gate (RAPEX) →

Action taken by the authority
Type of economic operator taking notified measure
Manufacturer
Category of measure
Marking the product with appropriate warnings on the risks
Primary source: https://ec.europa.eu/safety-gate-alerts/screen/webReport/alertDetail/10118541

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.